SEQIRUS USA INC.

ARMITAS

Vaccines; blood products, namely, immunoglobulins for medical or clinical use; serums for the treatment of influenza; antibodies; influenza vaccines; adjuvants and antigens; pharmaceutical preparations and substances for the treatment and/or prevention of blood or bleeding disorders, or diseases caused by bacteria and viruses; blood products, namely, blood plasma, and reagent blood cells; products derived from blood and products derived from recombinant DNA technology, namely, immunoglobulins, human albumin, blood clotting factors, plasma volume expanders, blood proteins for therapeutic use; serums, namely, anti-venoms; medicated serums for the treatment of blood or bleeding disorders; test kits, namely, invitro diagnostic reagent test kits for use in detecting cell mediated immune response; pharmaceutical preparations and substances, namely, RhD reagents for the detection of specific antigens or in blood typing; pharmaceutical preparations, namely, reagent red blood cells used to detect antibodies or IgG subtypes; pharmaceutical preparations, namely, monoclonal and polyclonal antibodies, and antibodies for use in the treatment of infectious diseases; pharmaceutical preparations, namely, reagents for medical/clinical use for the typing and detection of specific blood cells, and the detection of relevant compliment components and immunoglobulin subtypes;Chemical and biological reagents for scientific use and/or for non-medical purposes; cell cultures and media for scientific use and/or for non-medical purposes; test kits for scientific and/or non-medical use for anti-body screening, blood grouping or for detection of specific blood cells, antigens or immunoglobulin subtypes; chemical preparations for scientific and/or industrial purposes; diagnostic and testing agents for scientific use and/or for non-medical purposes; chemical and biological reagents for industrial use for anti-body screening, blood grouping, and for the typing and detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes; chemical test kits for the detection of specific blood cells, determining the presence of antigens on blood cells, and the detection of relevant complement compounds and immunoglobulin subtypes for laboratory or research use; chemical preparations for industrial use for anti-body screening, blood grouping, and the typing and detection of specific blood cells;Providing medical information concerning blood products; providing medical information concerning vaccines, anti-venoms, antivirals and immunohaematology products, namely, diagnostic reagents; and patent support services, namely, providing an internet based database of patient medical information concerning blood products, vaccines, anti-venoms, antivirals and immunhaematology products where patients can inquire about medical issues and procedures from other patients and can relay information about their medical experiences for support and community;

BE WELL. PASS IT ON

Promoting public awareness of the need for influenza immunization and vaccination programs;Healthcare and healthcare information services, namely, providing information concerning influenza immunization and vaccination programs;

HOME OF THE FLU FIGHTERS

Promotion of awareness of influenza immunization and vaccination programs;Healthcare and healthcare information services, namely, providing information concerning influenza immunization and vaccination programs;

HOME OF THE FLU FIGHTERS

Promotion of awareness of influenza immunization and vaccination programs;Healthcare and healthcare information services, namely, providing information concerning influenza immunization and vaccination programs;

RALLY

Promotion of influenza immunization and vaccination programs and the use of influenza vaccines by means of arranging and conducting incentive reward programs that allow healthcare providers to redeem the value of unused doses of influenza vaccine for a certificate redeemable for future purchases of influenza vaccine;

SHARE THE WELLNESS

Printed matter and publications, namely, brochures, leaflets, letters, cards and posters in the field of influenza immunization and vaccination;Promoting public awareness of the need for influenza immunization and vaccination programs;Healthcare and healthcare information services, namely, providing information concerning influenza immunization and vaccination programs;

SPREAD THE WELLNESS BE FLU-FREE ALL SEASON LONG

The mark consists of the words SPREAD THE WELLNESS on a rectangular banner extending at an upward angle across a circular background having a circular perimeter bearing the words BE FLU-FREE above the banner and ALL SEASON LONG below the banner.;Color is not claimed as a feature of the mark.;Promoting public awareness of the need for influenza immunization and vaccination programs;Healthcare and healthcare information services, namely, providing information concerning influenza and vaccination programs;